THE PROGNOSTIC EFFECT OF KNOWN AND NEWLY DETECTED TYPE 2 DIABETES IN PATIENTS WITH ACUTE CORONARY SYNDROMES

Glucose metabolism was evaluated with fasting glucose in plasma, HbA1c and a standard two-hour oral glucose tolerance test. The clinical outcome parameters were composition of all-cause mortality or myocardial infarction (MI) and major adverse cardiac events (MACE), including all-cause mortality, MI...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A1826-A1826
Hauptverfasser: Bjarnason, Thorarinn Arni, Hafthorsson, Steinar, Kristinsdottir, Linda, Oskarsdottir, Erna Sif, Aspelund, Thor, Sigurdsson, Sigurdur, Gudnason, Vilmundur, Andersen, Karl
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A1826
container_issue 11
container_start_page A1826
container_title Journal of the American College of Cardiology
container_volume 71
creator Bjarnason, Thorarinn Arni
Hafthorsson, Steinar
Kristinsdottir, Linda
Oskarsdottir, Erna Sif
Aspelund, Thor
Sigurdsson, Sigurdur
Gudnason, Vilmundur
Andersen, Karl
description Glucose metabolism was evaluated with fasting glucose in plasma, HbA1c and a standard two-hour oral glucose tolerance test. The clinical outcome parameters were composition of all-cause mortality or myocardial infarction (MI) and major adverse cardiac events (MACE), including all-cause mortality, MI, stroke, congestive heart failure requiring hospitalization and unstable angina requiring percutaneous coronary intervention.
doi_str_mv 10.1016/S0735-1097(18)32367-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2014383750</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109718323672</els_id><sourcerecordid>2014383750</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1300-a24f9fcfbdddbcec1d1cc99d67ea421e71f678f662a1a94b86f5466c16aba1d13</originalsourceid><addsrcrecordid>eNqFkE1Lw0AQhhdRsFZ_grDgRQ_RnXxskpPEZNMG66YkW0pOS7rZQOpHatIK_nvTVrx6Gph53hnmQegayD0QoA85cS3HAOK7t-DdWaZFXcM8QSNwHM-wHN89RaM_5Bxd9P2aEEI98EfoVUwZnmfphKe5SELM4piFAqcxfubpkuOAR5iz5azAERPDhEVYFHOGTRwlwdPQynHC8TwQCeMix8tETHEQLgTDYZqlPMgKnBc8ytIXll-is7p86_XVbx2jRcxEODVm6SQJg5mhwCLEKE279mtVr6qqWimtoAKlfL-iri5tE7QLNXW9mlKzhNK3Vx6tHZtSBbRclQNsjdHNce-maz93ut_KdbvrPoaT0iRgW57lOmSgnCOlurbvO13LTde8l923BCL3XuXBq9xLk-DJg1dpDrnHY04PL3w1upO9avSH0lXTabWVVdv8s-EHWD52ag</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2014383750</pqid></control><display><type>article</type><title>THE PROGNOSTIC EFFECT OF KNOWN AND NEWLY DETECTED TYPE 2 DIABETES IN PATIENTS WITH ACUTE CORONARY SYNDROMES</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via ScienceDirect (Elsevier)</source><source>Alma/SFX Local Collection</source><creator>Bjarnason, Thorarinn Arni ; Hafthorsson, Steinar ; Kristinsdottir, Linda ; Oskarsdottir, Erna Sif ; Aspelund, Thor ; Sigurdsson, Sigurdur ; Gudnason, Vilmundur ; Andersen, Karl</creator><creatorcontrib>Bjarnason, Thorarinn Arni ; Hafthorsson, Steinar ; Kristinsdottir, Linda ; Oskarsdottir, Erna Sif ; Aspelund, Thor ; Sigurdsson, Sigurdur ; Gudnason, Vilmundur ; Andersen, Karl</creatorcontrib><description>Glucose metabolism was evaluated with fasting glucose in plasma, HbA1c and a standard two-hour oral glucose tolerance test. The clinical outcome parameters were composition of all-cause mortality or myocardial infarction (MI) and major adverse cardiac events (MACE), including all-cause mortality, MI, stroke, congestive heart failure requiring hospitalization and unstable angina requiring percutaneous coronary intervention.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(18)32367-2</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Acute coronary syndromes ; Cardiology ; Cardiovascular disease ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Health risk assessment ; Metabolism ; Mortality</subject><ispartof>Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A1826-A1826</ispartof><rights>2018 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Mar 10, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0735-1097(18)32367-2$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Bjarnason, Thorarinn Arni</creatorcontrib><creatorcontrib>Hafthorsson, Steinar</creatorcontrib><creatorcontrib>Kristinsdottir, Linda</creatorcontrib><creatorcontrib>Oskarsdottir, Erna Sif</creatorcontrib><creatorcontrib>Aspelund, Thor</creatorcontrib><creatorcontrib>Sigurdsson, Sigurdur</creatorcontrib><creatorcontrib>Gudnason, Vilmundur</creatorcontrib><creatorcontrib>Andersen, Karl</creatorcontrib><title>THE PROGNOSTIC EFFECT OF KNOWN AND NEWLY DETECTED TYPE 2 DIABETES IN PATIENTS WITH ACUTE CORONARY SYNDROMES</title><title>Journal of the American College of Cardiology</title><description>Glucose metabolism was evaluated with fasting glucose in plasma, HbA1c and a standard two-hour oral glucose tolerance test. The clinical outcome parameters were composition of all-cause mortality or myocardial infarction (MI) and major adverse cardiac events (MACE), including all-cause mortality, MI, stroke, congestive heart failure requiring hospitalization and unstable angina requiring percutaneous coronary intervention.</description><subject>Acute coronary syndromes</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Health risk assessment</subject><subject>Metabolism</subject><subject>Mortality</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFkE1Lw0AQhhdRsFZ_grDgRQ_RnXxskpPEZNMG66YkW0pOS7rZQOpHatIK_nvTVrx6Gph53hnmQegayD0QoA85cS3HAOK7t-DdWaZFXcM8QSNwHM-wHN89RaM_5Bxd9P2aEEI98EfoVUwZnmfphKe5SELM4piFAqcxfubpkuOAR5iz5azAERPDhEVYFHOGTRwlwdPQynHC8TwQCeMix8tETHEQLgTDYZqlPMgKnBc8ytIXll-is7p86_XVbx2jRcxEODVm6SQJg5mhwCLEKE279mtVr6qqWimtoAKlfL-iri5tE7QLNXW9mlKzhNK3Vx6tHZtSBbRclQNsjdHNce-maz93ut_KdbvrPoaT0iRgW57lOmSgnCOlurbvO13LTde8l923BCL3XuXBq9xLk-DJg1dpDrnHY04PL3w1upO9avSH0lXTabWVVdv8s-EHWD52ag</recordid><startdate>20180310</startdate><enddate>20180310</enddate><creator>Bjarnason, Thorarinn Arni</creator><creator>Hafthorsson, Steinar</creator><creator>Kristinsdottir, Linda</creator><creator>Oskarsdottir, Erna Sif</creator><creator>Aspelund, Thor</creator><creator>Sigurdsson, Sigurdur</creator><creator>Gudnason, Vilmundur</creator><creator>Andersen, Karl</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20180310</creationdate><title>THE PROGNOSTIC EFFECT OF KNOWN AND NEWLY DETECTED TYPE 2 DIABETES IN PATIENTS WITH ACUTE CORONARY SYNDROMES</title><author>Bjarnason, Thorarinn Arni ; Hafthorsson, Steinar ; Kristinsdottir, Linda ; Oskarsdottir, Erna Sif ; Aspelund, Thor ; Sigurdsson, Sigurdur ; Gudnason, Vilmundur ; Andersen, Karl</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1300-a24f9fcfbdddbcec1d1cc99d67ea421e71f678f662a1a94b86f5466c16aba1d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acute coronary syndromes</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Health risk assessment</topic><topic>Metabolism</topic><topic>Mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bjarnason, Thorarinn Arni</creatorcontrib><creatorcontrib>Hafthorsson, Steinar</creatorcontrib><creatorcontrib>Kristinsdottir, Linda</creatorcontrib><creatorcontrib>Oskarsdottir, Erna Sif</creatorcontrib><creatorcontrib>Aspelund, Thor</creatorcontrib><creatorcontrib>Sigurdsson, Sigurdur</creatorcontrib><creatorcontrib>Gudnason, Vilmundur</creatorcontrib><creatorcontrib>Andersen, Karl</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bjarnason, Thorarinn Arni</au><au>Hafthorsson, Steinar</au><au>Kristinsdottir, Linda</au><au>Oskarsdottir, Erna Sif</au><au>Aspelund, Thor</au><au>Sigurdsson, Sigurdur</au><au>Gudnason, Vilmundur</au><au>Andersen, Karl</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THE PROGNOSTIC EFFECT OF KNOWN AND NEWLY DETECTED TYPE 2 DIABETES IN PATIENTS WITH ACUTE CORONARY SYNDROMES</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2018-03-10</date><risdate>2018</risdate><volume>71</volume><issue>11</issue><spage>A1826</spage><epage>A1826</epage><pages>A1826-A1826</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Glucose metabolism was evaluated with fasting glucose in plasma, HbA1c and a standard two-hour oral glucose tolerance test. The clinical outcome parameters were composition of all-cause mortality or myocardial infarction (MI) and major adverse cardiac events (MACE), including all-cause mortality, MI, stroke, congestive heart failure requiring hospitalization and unstable angina requiring percutaneous coronary intervention.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(18)32367-2</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A1826-A1826
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_2014383750
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via ScienceDirect (Elsevier); Alma/SFX Local Collection
subjects Acute coronary syndromes
Cardiology
Cardiovascular disease
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Health risk assessment
Metabolism
Mortality
title THE PROGNOSTIC EFFECT OF KNOWN AND NEWLY DETECTED TYPE 2 DIABETES IN PATIENTS WITH ACUTE CORONARY SYNDROMES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T23%3A50%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THE%20PROGNOSTIC%20EFFECT%20OF%20KNOWN%20AND%20NEWLY%20DETECTED%20TYPE%202%20DIABETES%20IN%20PATIENTS%20WITH%20ACUTE%20CORONARY%20SYNDROMES&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Bjarnason,%20Thorarinn%20Arni&rft.date=2018-03-10&rft.volume=71&rft.issue=11&rft.spage=A1826&rft.epage=A1826&rft.pages=A1826-A1826&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(18)32367-2&rft_dat=%3Cproquest_cross%3E2014383750%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2014383750&rft_id=info:pmid/&rft_els_id=S0735109718323672&rfr_iscdi=true